DVx Inc.
Q1 FY2027 Financial Results Summary (Consolidated)
The consolidated net sales for the first quarter of FY2027 are JPY 15,088 million, an increase of 9.6% YoY. Operating profit is JPY 2,805 million, and net profit is JPY 6,691 million, both showing increases. Segments such as arrhythmia and ischemia business are performing well.
Key Figures
- Net Sales: JPY 15,088 million (YoY +9.6%)
- Operating Profit: JPY 2,805 million (YoY +23.1%)
- Net Profit: JPY 6,691 million (YoY +162.0%)
AI要約
Performance Overview
DeepX's consolidated financial results for the first quarter of FY2027 show net sales of JPY 15,088 million (+9.6% YoY), operating profit of JPY 2,805 million (+23.1% YoY), and net profit of JPY 6,691 million (+162.0% YoY), representing significant growth. The positive performance was driven mainly by strong results in the arrhythmia and ischemia businesses, with improvements in cost management and contributions from new products also boosting profitability.
Outlook and Impact on Investors
Future growth is expected through the continued launch of new products and market expansion, with ongoing increases in sales and profits. Particular attention is on the growth of the ischemia segment, which is anticipated to strengthen the overall revenue foundation. For investors, strong performance and growth strategies are likely to enhance stock value.
Net Sales Trend
Operating Profit Trend
Net Profit Trend
DeepX Inc.
Company overview · Stock price · Financial data · All IR
